Trastuzumab/Hyaluronidase (Alteogen)

曲妥珠单抗/透明质酸酶（Alteogen）

Report date: 2025/03/07 17:33:40

Base Information

Drug NameTrastuzumab/Hyaluronidase (Alteogen)

Drug Alias NameTrastuzumab/HyaluronidaseHyaluronidase-oysk/Trastuzumab

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsHyaluronic acid modulators

TargetsHyaluronic acidReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlteogen Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlteogen Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A